By: Amerigo Allegretto From: auntminnie.com Annual mammography with a clinical exam — rather than semiannual — is “likely sufficient” for women who have undergone breast-conserving surgery and were treated with neoadjuvant therapy, a study published March 2 in Surgical Oncology Insight has found. Researchers led by Ton Wang, MD, from Cedars-Sinai Medical Center in Los Angeles found insufficient evidence supporting …
Neoadjuvant and Adjuvant Therapy Elicit Similar Efficacy in Early-Stage HER2+ Breast Cancer
By: Chris Ryan From: onclive.com Neoadjuvant therapy generated similar benefits to adjuvant therapy in patients with early-stage, HER2-positive breast cancer treated in China, suggesting that neoadjuvant therapy should be used in this patient population, according to data from a real-world retrospective study published in The Breast.1 At a median follow-up of 54.1 months (interquartile range, 40.8-68.9), all patients treated with …
Survival Effect of pCR Elusive in Breast Cancer
By: Charles Bankhead, Senior Editor From: medpagetoday.com 80% lower risk of recurrence with surrogate endpoint, but link to survival unproven Neoadjuvant therapy that resulted in pathologic complete response (pCR) reduced the risk of breast cancer recurrence by 80%, pooled data from a phase II clinical trial platform showed. The results held up across all breast cancer subtypes and treatment regimens, …